TI
PTCT icon

Turner Investments’s PTC Therapeutics PTCT Stock Holding History

Turner Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-47,280
Closed -$1.53M – 246
2015
Q4 		$1.53M Buy
+47,280
New +$1.39M 0.32% 93
2015
Q2 		– Sell
-52,760
Closed -$3.21M – 355
2015
Q1 		$3.21M Buy
+52,760
New +$3.22M 0.58% 55

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Turner Investments's PTCT Position: Q1 2016 in Review

Turner Investments sold out of PTC Therapeutics (PTCT) in Q1 2016, closing a stake of 47,280 shares — an estimated $1.53M sold.

Turner Investments first reported a position in PTCT in Q1 2015 and held it in 2 quarters. The position peaked at $3.21M in Q1 2015. 119 funds tracked by Wall St. Rank hold PTCT as of Q1 2016.

  • Turner Investments reported no remaining PTC Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Turner Investments sold 47,280 PTC Therapeutics shares in Q1 2016, an estimated $1.53M.
  • Turner Investments first reported a position in PTC Therapeutics in Q1 2015 and held it in 2 quarters.
  • Turner Investments's PTC Therapeutics position peaked at $3.21M in Q1 2015.
  • 119 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.